- 19 Dec
The Maryland Racing Commission has made available a booklet of guidelines for Maryland horsemen to explain the recently and ensure compliance with the recently adopted Mid Atlantic Uniform Medication and Drug Testing Program which begins on January 1, 2014.
Under the Mid-Atlantic Uniform Medication Program, drugs and medications are divided into two categories: Controlled Therapeutic Substances and Prohibited Substances. This booklet contains the current list of the 24 Controlled Therapeutic Substances, together with recommended dosage advice and withdrawal times and the uniform laboratory detection thresholds to be employed by the testing laboratories.
These therapeutic medications were identified following intensive consultation, administration studies and scientific review among the American Association of Equine Practitioners (AAEP), the Racing Medication and Testing Consortium (RMTC), the Association of Racing Commissioners International (ARCI) the Thoroughbred Horsemen’s Association, and the industry's chemists and pharmacologists. The guidelines, if followed, will enable the therapeutic treatment of the horse while ensuring that no pharmacologically significant residue of the medication will be present in the horse during a race.
In addition, under the new rules set to begin, Salix will become the only drug permitted to be administered to a horse within 24 hours of its race. It is required that Salix be administered by a racing commission-designated veterinarian. These procedures are also detailed in the booklet.
Maryland will join New York, New Jersey, Pennsylvania, Delaware, Virginia, West Virginia, and Massachusetts in the implementation of this uniform program. A large number of racing states throughout the United States have committed to adopt this Program in 2014 and it is anticipated that these reforms will become the new national medication system.